Medical Research News
Focus on the latest clinical studies, reports, findings, programs and standards covering a wide spectrum of medical and health issues. This section highlights research into human populations and includes information about research facilities, funding, resources and public policy.
Whistleblowers Report Substantial Stresses, Limited Support When Helping Expose Health Care Fraud - Research from BWH
New research evaluates the motivations and experiences of whistleblowers responsible for the recent wave of federal health care fraud cases and finds that, despite their altruistic goals, whistleblowers experience substantial hardships. - June 21, 2010 - Brigham and Women’s Hospital
Brigham Renal Division Research at the Center of an International Effort to Identify Next Generation Biomarkers to Screen Kidney Toxicity
New research has resulted in the approval of Kidney Injury Molecule-1 (Kim-1) as a highly sensitive and specific marker of drug-induced kidney injury by both the FDA and EMA. - June 21, 2010 - Brigham and Women’s Hospital
Clinical Pharmacology Study Group (CPSG) Announces Open Enrollment for Fibromyalgia Studies
The Clinical Pharmacology Study Group (CPSG) is currently participating in several clinical trials for fibromyalgia in their Worcester, MA facility. Subjects who enroll in a clinical trial are carefully selected from a list of inclusion and exclusion criteria designed to ensure safety for the... - June 18, 2010 - Clinical Pharmacology Study Group
ALPCO Diagnostics Exclusively Offers Animal NGAL Assays from BioPorto
BioPorto Diagnostics has awarded ALPCO Diagnostics exclusive distributorship for its animal NGAL ELISAs to the North American market. BioPorto’s prominence is unrivaled in immunoassays for measuring NGAL (neutrophil gelatinase associated lipocalin) – the breakthrough kidney injury... - June 17, 2010 - ALPCO
Risk of Suicide, Suicide Attempt Similar Across Types of Antidepressant Medication
New research shows that among adults beginning antidepressant therapy, the risk of suicide or suicide attempts does not appear to vary by individual type or class of medication. - June 13, 2010 - Brigham and Women’s Hospital
BWH Researchers Find That Using Bar-Code Technology with eMAR Drastically Reduces Medication Administration and Transcription Errors
Researchers found that using both bar-code technology and eMAR together substantially reduces transcription and medication adminstration errors. - June 13, 2010 - Brigham and Women’s Hospital
Green Light Affects Circadian Rhythms
Researchers show that green light is effective in eliciting non-visual responses to light such as resetting circadian rhythms, affecting melatonin production and alerting the brain. - June 13, 2010 - Brigham and Women’s Hospital
Romantic Comedy Film "Love Simple" Donating Proceeds to S.L.E. Lupus Foundation
June 14—June 21, 30% of Sales on iTunes Will Help Raise Funds, Awareness for Lupus - June 12, 2010 - S.L.E. Lupus Foundation
Chiropractic Helps with Brain and Spinal Cord Disorder According to Journal of Pediatric, Maternal & Family Health – Chiropractic
Recent research reported in the Journal of Pediatric, Maternal & Family Health – Chiropractic regarding improvement in an 11 year old girl undergoing chiropractic care reveals that chiropractic could play an important role in managing brain related neurological disorders. - June 12, 2010 - J. Pediatric, Maternal & Family Health - Chiropractic
Researchers Study Perceived Discrimination in Relation to Risk of Death in African American Women
In a recent study, researchers at Brigham and Women’s Hospital (BWH) and Boston University Sloan School of Epidemiology found no direct association between perceived racism and risk of death in African American Women. - June 12, 2010 - Brigham and Women’s Hospital
Pemphigus-Pemphigoid Patient Registry Launched
The world's largest pemphigus and pemphigoid patient support organization, the International Pemphigus & Pemphigoid Foundation, has launched its Pemphigus-Pemphigoid Patient Registry. The Registry will use patient-provided illness and treatment/outcome information to assist researchers in their search for a cure. - June 11, 2010 - International Pemphigus Pemphigoid Foundation
ALPCO Diagnostics Prepares for Launch of Unique Immunoassays
ALPCO Diagnostics announces the recent hiring of Leon F. Hebert Jr., Ph.D. As ALPCO’s new Diabetes and Obesity Product Manager, Dr. Hebert will be charged with overseeing the launch of several new ELISA research tools, including: Mouse Proinsulin ELISA, Rat Proinsulin ELISA, Mouse C-peptide... - June 09, 2010 - ALPCO
Eden Autism Services Once Again Delivers Impressive Princeton Lecture Series
Princeton University’s Reynolds Auditorium was the site of the 16th annual Eden Autism Services Princeton Lecture Series, Affecting the Research and Service Agenda. The day-long conference, which is sponsored by Eden, a New Jersey-based nonprofit organization serving individuals with autism,... - June 08, 2010 - Eden Autism Services
Lupus Research Institute Hails Results of CellCept® Trial in People with Lupus Kidney Disease
The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations are very encouraged by trial results released by Vifor Pharma, Galencia Group, and Roche demonstrating that the drug CellCept® (mycophenolate mofetil) helps in maintaining remission of lupus... - June 05, 2010 - Lupus Research Institute
North American Seminars, Inc. Redefines Physical Therapy Continuing Education Courses Online with New Delivery Platform
North American Seminars Inc. introduces a new continuing education course software platform for delivery of physical therapy continuing education courses. This platform is called Healthclick LMS and can deliver continuing education courses online across the globe. New online courses will be introduced each month. - May 29, 2010 - North American Seminars
Accord Clinical Research Announces Ulcerative Proctitis Research Studies in Daytona Beach, Florida
Accord Clinical Research, a privately owned research facility, located in Port Orange, Florida, announces their latest research study to test investigational treatment options for those already diagnosed with ulcerative proctitis. - May 21, 2010 - Avail Clinical Research
IonSense Issued Three Patents Related to Direct Analysis in Real Time Mass Spectrometry
Supports Current Products and Applications in Food Safety, Pharmaceutical Development, and Forensics - May 20, 2010 - IonSense, Inc.
Jean Brown Research Announces Participation in a Phase II/III Clinical Trial of Investigational Vaccine Used to Prevent Infection in Cardiothoracic Surgery Patients
Jean Brown Research Announces Its Participation in a Phase II/III Clinical Trial of an Investigational Vaccine Used to Prevent Staphylococcus Aureus Infection in Patients Undergoing Cardiothoracic Surgery. - May 19, 2010 - Jean Brown Research
Voicebrook to Exhibit at 2010 PowerPath® Users Conference
Company to demonstrate industry-leading solutions at Impac’s 2010 Annual Users Group Meeting in Amelia Island, Florida - May 19, 2010 - Voicebrook, Inc.
VIRUN® to Premiere OmegaH2O® Through WEDAR at CPhI and HI/NI in Shanghai, China
Virun to premiere water soluble and shelf stable OmegaH2O® in China through WEDAR Biotechnology Co. Ltd. OmegaH2O® is patents pending. - May 18, 2010 - VIRUN
Statistics Confirm That Botox Training Spells Success for Capturing Minimally-Invasive Market
The International Association for Physicians In Aesthetic Medicine (IAPAM) offers the industry's leading hCG for weight loss, aesthetic medicine and Botox training for physicians. The IAPAM's Aesthetic Medicine Symposium offers the most comprehensive clinical and business training for doctors looking to add minimally-invasive procedures to a healthcare business. The IAPAM's training focuses on combining the top-5 non-invasive procedures in order to create a successful aesthetic practice. - May 12, 2010 - International Association for Physicians in Aesthetic Medicine
New Brigham and Women’s Hospital Report Brings Lung Cancer in Women Out of the Shadows
BWH releases the most current and comprehensive overview of the impact of lung cancer on women. - May 12, 2010 - Brigham and Women’s Hospital
World of Lupus Research Expands as Florida Joins the Lupus Research Institute's National Coalition
Addition of State of Florida on World Lupus Day 2010 Pumps Extra Strength into Patient’s Voice for Lupus Research - May 11, 2010 - Lupus Research Institute
Cepoint Launches HD-SDI Multiple Channel DVR with IRIG-B or GPS Frame-Time Stamp
Cepoint Networks, LLC launched its RGB(HDTV) and HD-SDI Multi-channel version of its HD Studio9000 Digital Video Recorder system with IRIG-B or GPS frame time-stamp capability. Model ST9000HDSD which is designed for High definition Broadcast and Surveillance video capturing and recording applications conforms to SMPTE 292 standard and has capability of simultaneous audio capture and recording. - May 11, 2010 - CePOINT Networks, LLC
Clinical Trial Compares Leading-Edge Treatments for Obesity and Diabetes
New Research Will Look at Weight Loss Stomach Surgery Versus Intensive Program of Lifestyle and Medical Management. - May 10, 2010 - Brigham and Women’s Hospital
HealthSaaS, Inc. Releasing Online Vertical Suite of Condition and Disease Specific Personal Health Records (PHR)
HealthSaaS today announced they are releasing an online suite of condition and disease specific Personal Health Record (PHR) services. The first to be released is PainPHR http://www.painPHR.com DiabetesPHR and SportsmedPHR will be available later this year. BreastcancerPHR and ProstatecancerPHR... - May 07, 2010 - HealthSaaS, Inc
RayBiotech Announces Biomarker Grant Awardees
RayBiotech, Inc., the Protein Array Pioneer Company, has announced the winners of its Biomarker Discovery Pilot Grant program. In total, 18 award recipients were chosen for grants of up to $20,000 each, redeemable for RayBiotech products and services. "By offering these grants," states Dr. - May 06, 2010 - RayBiotech, Inc
National Patient Safety Foundation Awards Grant to Research Safety of Computerized Ordering of Medications
Quantros MEDMARX medication error reporting system will be linchpin of new patient safety research project. - April 29, 2010 - Quantros Inc.
Lupus Research Institute: News on Possible Drug for Lupus—Benlysta™
Human Genome Sciences (HGS) and GlaxoSmithKline Report Topline Results of 76-Week, Phase 3 Study - April 22, 2010 - Lupus Research Institute
Clinical Research Coordinators Create Niche Business Offering Clinical Research Expertise to Private Medical Practices in Florida
Clinical Research Coordinators Deborah Eyerdam and Diane Paquet, both of South Florida, have partnered to create Certified Clinical Research Coordinators of Florida, a private company that will provide training and temporary staffing for MDs looking to expand their businesses and add a new income... - April 17, 2010 - Certified Clinical Research Coordinators of Florida
Landmark Lung Cancer Research Study Approves Only Site in Colorado
Denver CyberKnife obtains IRB approval as the only site in Colorado to participate in a phase IIII lung cancer trial comparing radiosurgery to surgery. - April 16, 2010 - Denver CyberKnife
Official Patent Approval for the "actiCAP" EEG Cap Approaches
The “actiCAP” active electrode system is to be officially recognized as an innovation with a US patent - April 16, 2010 - Brain Products GmbH
Vitamin D May Protect from Cardiovascular Events
Researchers stress importance of large scale clinical trials to confirm the role of both vitamin D and calcium in the prevention of cardiovascular disease. - April 16, 2010 - Brigham and Women’s Hospital
Eden Spine Receives New Patent for Its Corpectomy Device, the GIZA™
Eden Spine, a Florida based Medical Devices organization focused on developing the latest generation of spinal technologies, is pleased to announce that the Patent for its corpectomy device, the GIZA™, was granted from the European Patent Office. “The GIZA™ allows Eden to provide... - March 26, 2010 - Eden Spine, LLC
International Stem Cell Corporation Begins Its Second Pre-Clinical Phase of Testing Retinal Pigment from Human Parthenogenetic Stem Cells
International Stem Cell Corporation, an international pioneer and leader in stem cell research, begins its second pre-clinical phase of testing retinal pigment epithelium (RPE) derived from human parthenogenetic stem cells for the treatment of retinal diseases. - March 24, 2010 - International Stem Cell Corporation
Female Hot Flash Research Study Continues
Avail Clinical Research conducting research studies on post menopausal women for hot flash treatments. - March 24, 2010 - Avail Clinical Research
U.S. Patent Granted for the Multimeric Adiponectin ELISA
A United States patent has been granted to Sekisui Medical Corp. (Tokyo, Japan), the inventors of the Multimeric Adiponectin ELISA. The Multimeric Adiponectin ELISA is distributed in the U.S. and Canada exclusively by ALPCO Diagnostics. - March 23, 2010 - ALPCO
Avail Clinical Research Announces Osteoarthritis Research Studies in DeLand, FL
Avail Clinical Research Announces Osteoarthritis Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 23, 2010 - Avail Clinical Research
Study Finds Many New Prescriptions Go Unfilled
Potential health benefits are not being realized because more than a quarter of new prescriptions are never filled. - March 14, 2010 - Brigham and Women’s Hospital
Researchers Identify Genetic Pathway Responsible for Metastatic Prostate Cancer
Four genes identified that are together a pathway responsible for driving metastatic prostate cancer. - March 14, 2010 - Brigham and Women’s Hospital
Avail Clinical Research Announces High Cholesterol Research Studies in DeLand, FL
Avail Clinical Research Announces High Cholesterol Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 12, 2010 - Avail Clinical Research
Avail Clinical Research Announces High Blood Pressure (Hypertension) Research Studies in DeLand, FL
Avail Clinical Research Announces High Blood Pressure (Hypertension) Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 10, 2010 - Avail Clinical Research
Bio-Synthesis Awarded NIH Grant to Develop Synergistic Adjuvants that Stimulate both Innate and Adaptive Immunities
BioSynthesis announces the award of a two-year phase I SBIR grant by NIH to further its development program of immune agonists. These new agents have in their chemical structure different determinants that stimulate both innate and acquired immunity, leading to synergistic effects on the immune response. These new immune agonists could be useful in the development of difficult vaccines such as HIV-1 and cancer vaccines. - March 09, 2010 - Bio-Synthesis Inc.
Pharmacodiagnostics and Personalized Medicine 2009 Markets, Challenges, Forecasts and Key Players Reports Now Available on ReportsandReports
Personalized Medicine has given the diagnostics field a huge boost in terms of publicity/public attention, revenue potential, and investment interest. Still questions exist as to how extensive such testing will be and how soon we will see its growth in clinical applications. - March 06, 2010 - marketsandmarkets
AVT-12 Weight Loss Drug Product Study Concludes
The weight loss combination drug product, AVT-12 has most recently been the subject of a year-long phase III randomized, double-blind, placebo-controlled efficacy trial, conducted by ITCES Corporation. - March 05, 2010 - ITCES Corporation
Avail Clinical Research Announces Hepatitis C Research Studies in DeLand, FL
Avail Clinical Research Announces Hepatitis Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida. - March 05, 2010 - Avail Clinical Research
ComFit Solution’s WAVE Vibration Therapy Study Shows Improvement in Strength and Motor Skills in Multiple Sclerosis Patients
A two-month vibration therapy study in Omaha with 70 Multiple Sclerosis (MS) patients has shown remarkable results. WAVE (Whole-body Advanced Vibration Exercise) technology has improved the patient‟s motor skills, decreased spasticity and increased flexibility. For the study, the training... - March 05, 2010 - ComFit Solutions, LLC
ICTS Provides Solutions for Rheumatology Study
Tom Sturgis, president of ICTS (Integrated Clinical Trial Services, LLC) (www.icts.us), has announced that the company has completed the development and implementation of a program designed to increase patient consent in a rheumatology study. The ongoing and parallel studies showed a low consent... - March 04, 2010 - Integrated Clinical Trial Services
Avail Clinical Research Announces Gout Research Studies in DeLand, FL
Avail Clinical Research Announces Gout Paid Research Studies & Paid Clinical Trials in DeLand, Orlando & Daytona Beach, Florida - March 03, 2010 - Avail Clinical Research
March is Endometriosis Awareness Month
Backed by Congressional legislation, the Endometriosis Research Center is again celebrating March as “Endometriosis Awareness Month” in honor of all those affected by the disease. Endometriosis is a painful reproductive and immunological disease in which tissue similar to the uterine... - March 02, 2010 - Endometriosis Research Center